Business Wire

MINISTRY-FOREIGN-JAPAN

29.2.2024 14:19:31 CET | Business Wire | Press release

Share
Japan Hosted a Conference to Boost Ukraine’s Economic Growth and Recovery

On February 19th, representatives of the governments of Japan and Ukraine, as well as business organizations, gathered in Tokyo for the Japan-Ukraine Conference for Promotion of Economic Growth and Reconstruction.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240229458562/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Prime Minister Kishida Fumio emphasized how Japan can contribute to Ukraine’s post-war reconstruction. (Photo by: Cabinet Public Affairs Office)

The Japanese government delegation, led by Prime Minister of Japan Kishida Fumio, pledged long-term support for Ukraine's recovery through public-private partnership. The Ukrainian delegation, led by Prime Minister of Ukraine Denys Shmyhal, thanked Japan for its assistance and invited Japanese businesses to invest in Ukraine's reconstruction. Each delegation consisted of more than 100 government and corporate officials. In total, around 300 people and 130 companies took part in the conference. The two governments agreed to cooperate on seven key areas: land mine action and debris clearance, humanitarian aid and livelihood reconstruction, agricultural development, biotechnology, digital and information technology, transportation and energy infrastructure, and anti-corruption and governance-strengthening measures.

In his keynote speech, Prime Minister Kishida described supporting Ukraine's recovery from the ongoing war as "investing in the future," and called on the international community to contribute. “Japan’s public and private sectors will all work together through an all-Japan approach, utilizing the knowledge derived from Japan’s postwar and disaster reconstruction efforts,” he said in his speech. “The promotion of economic reconstruction, however, is not only investment for the future of Ukraine but also investing in Japan and the whole globe.” He outlined new initiatives for Japan's public and private sectors to support Ukraine. Kishida also announced that Japan would ease entry visa requirements for Ukrainian citizens involving in Japan-Ukraine cooperation projects.

Prime Minister Shmyhal thanked Japan for its ongoing assistance and Prime Minister Kishida for his visit to Ukraine in 2023. He added “Today’s conference will be the next step towards continuing the development of both countries’ relationships.” Shmyhal mentioned the financial success of Japanese companies in Ukraine so far and invited businesses to further invest in the coming “Ukrainian economic miracle.” He underlined key sectors such as energy, agriculture, and infrastructure as offering prime investment opportunities with robust growth potential.

Both leaders emphasized their commitment to cooperation, as well as the importance of the private sector in Ukraine's reconstruction.

The conference resulted in the announcement of 56 documents, including inter-governmental agreements. The two governments signed a convention eliminating double taxation, which will support Japanese companies to invest in Ukraine. They also signed an agreement on bilateral crediting, exchanged notes concerning a grant aid for emergency recovery, and pledged to collaborate in the fields of education and technology.

Other documents included deals between government agencies and individual businesses and business organizations. Japanese companies signed deals with Ukrainian companies and government agencies to develop energy facilities, rebuild infrastructure, remove land mines, and more.

Since the Russian invasion in February 2022, Japan has consistently provided humanitarian aid and other assistance to Ukraine. With the public-private partnership announced at this conference, Japan plans to use its technological expertise and experience in post-disaster recovery and reconstruction to strengthen its support for Ukraine.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240229458562/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Codethink Opens Early Access to IEC 61508 Mapping for the Eclipse Trustable Software Framework11.3.2026 08:07:00 CET | Press release

Preview release invites industry collaboration on open source approach to functional safety assessment EMBEDDED WORLD--Codethink today opened early access to its mapping between the Eclipse Trustable Software Framework (TSF) and IEC 61508, the international standard governing the functional safety of electrical and electronic systems. The mapping establishes a transparent relationship between the engineering principles of the Trustable Software Framework and the objectives defined in IEC 61508. By making this work available as an early preview, Codethink is inviting organisations interested in applying open source approaches to functional safety to review and begin working with the mapping while the work continues to mature. IEC 61508 forms the foundation of many domain-specific safety standards, including ISO 26262 for automotive systems. The early access reflects Codethink’s long-standing commitment to open development of software engineering methods. “This preview release reflects o

Galderma Buys Back Shares Worth CHF 232 Million in the Context of Accelerated Bookbuild Offering11.3.2026 07:00:00 CET | Press release

Ad hoc announcement pursuant to Art. 53 LR Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that it has agreed to repurchase 1.6 million shares at a price of CHF 143.75 per share for a total consideration of CHF 232 million in the context of the accelerated bookbuild offering (“ABO”) of Galderma shares by Sunshine SwissCo GmbH (“EQT”), Abu Dhabi Investment Authority (Private Equities Department) and Auba Investment Pte. Ltd. (all together the “Selling Shareholders”) launched yesterday evening. The repurchase was made at the same price per share determined by the bookbuilding offering. As a result of yesterday evening’s ABO, the Selling Shareholders have fully divested their remaining stake in Galderma. The repurchase, which is expected to settle on March 13 is being financed by Galderma’s existing liquidity on hand and will not affect the company’s ability to deliver on its strategic and financing priorities. The shares will be held in treasury for futur

Thales Launches SkyDefender: The Integral Air and Missile Defence Dome With Artificial Intelligence11.3.2026 07:00:00 CET | Press release

SkyDefender is a multi-layer, multi-domain Integrated Air and Missile Defence system providing full protection against all types of air threats, on land, at sea and in space. SkyDefender integrates a network of advanced sensors and effectors with a versatile command and control (C2) system. With its open and modular architecture, it is fully compatible with existing air defence systems. Combining Thales’ expertise in cybersecurity and advanced artificial intelligence through cortAIx, Thales AI accelerator, SkyDefender enables operational superiority and proactive defence against cyberattacks and evolving threats. Thales is capable of delivering this critical protection globally from today. As air and missile threats are evolving faster than ever, from slow-moving drones to hypersonic missiles, attacks are becoming increasingly complex, saturating and unpredictable. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260310398606/

Curatis and Neupharma Announce Exclusive Licensing Agreement to Develop and Market Corticorelin (C-PTBE-01) for the Treatment of Peritumoral Brain Edema in Japan11.3.2026 07:00:00 CET | Press release

Japan is one of the world's most important pharmaceutical markets after the US and Europe. Neupharma’s team has extensive experience in developing and successfully commercialising orphan drugs as well as speciality care medicines in Japan, including a blockbuster drug. The agreement with Neupharma includes upfront and milestone payments of up to CHF 83.5 million as well as royalties of up to 20% on sales. The population of available patients eligible for corticorelin treatment associated with peritumoral brain edema is estimated at 60,000 in Japan and 500,000 worldwide. Global market potential is forecasted to exceed USD 1 billion annually. Curatis Holding AG (SIX: CURN) and Neupharma Co., Ltd. (“Neupharma”), a Japanese pharmaceutical company specializing in oncology, immunology, pulmonology and cardiology disorders, today announce an exclusive license and development agreement for corticorelin (C-PTBE-01) in Japan. Under the terms of the agreement, Neupharma will receive exclusive rig

Galderma Completes Successful Placement of EUR 500 Million Eurobond11.3.2026 06:55:00 CET | Press release

Galderma Group AG (SWX:GALD): NOT FOR DISTRIBUTION IN THE UNITED STATES OR IN ANY OTHER JURISDICTION IN WHICH SUCH DISTRIBUTION WOULD BE RESTRICTED BY APPLICABLE LAW OR REGULATION. Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced the successful placement of a single-tranche EUR 500 million Eurobond. The bond has a 5-year maturity and carries a fixed-rate annual coupon of 3.375%. The Eurobond was placed on March 10, 2026, with settlement expected on March 17, 2026, and will be listed on the SIX Swiss Exchange. Citigroup, ING, J.P. Morgan and RBC Capital Markets jointly led the transaction. Net proceeds from the transaction will be used to fully repay Galderma’s existing bank term loan issued in connection with the company’s initial public offering in March 2024. The transaction represents the final step in Galderma’s refinancing process, having obtained two investment grade credit ratings. Galderma is currently rated ‘BBB’ (stable outlook) by Fitc

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye